Can ventilator-associated pneumonia in the ICU be reduced in patients with traumatic brain injury who use an oral rinse containing sodium bicarbonate?

Researchers compared the effects of macrolides in combination with either ampicillin or ceftriaxone among patients hospitalized with community-acquired pneumonia.

How does lung ultrasound compare with thoracic computed tomography in determining the severity of COVID-19 pneumonia?

Researchers assessed potential risk factors associated with 30-day mortality among patients with Acinetobacter baumannii complex bacteremia.

Researchers assessed the safety and effectiveness of twice-daily dolutegravir dosing plus rifampicin in children with HIV-associated tuberculosis infection.

Researchers assessed whether normal oxygenation is an indicator for the early discontinuation of antibiotic treatment in patients hospitalized with pneumonia.

Researchers assessed the reactogenicity of COVID-19 mRNA vaccine boosters coadministered with a seasonal influenza vaccine.

Should clofazimine remain a “second-choice agent” for treating patients with multidrug-resistant tuberculosis? A meta-analysis reviews the current evidence.

In general, routine annual vaccination is recommended for all patients 6 months of age and older who have no contraindications and should be completed by the end of October.

Researchers assessed the effect of adjunctive corticosteroid therapy on mortality outcomes in patients with rheumatic diseases complicated by Pneumocystis jirovicii pneumonia.

Researchers assessed the safety and immunogenicity of a novel seasonal influenza vaccine adjuvanted with hydroxypropropyl-β-cyclodextrin.

Researchers assessed the ability of a machine learning model to predict the risk of 30-day mortality among patients with community-acquired pneumonia.

Researchers assessed temporal and regional trends to estimate the global rate of macrolide-resistant Mycoplasma pneumoniae infections.

Researchers assessed whether point-of-care multiplex polymerase chain reaction testing for respiratory pathogens decreases the rate of untargeted antibiotic therapy in children.

Researchers assessed treatment outcomes among women with multidrug-resistant tuberculosis infection during pregnancy.

Could thoracic HRCT semiquantitative scoring offer a rapid and accurate method for identifying patients with severe COVID-19 who are at risk for poor outcomes?

Researchers evaluated 3 different study designs to determine their accuracy in measuring influenza vaccine effectiveness among older patients.

Researchers compared the risk for pneumonia and sepsis in patients with type 2 diabetes on sodium-glucose contransporter-2 vs dipeptidyl peptidase-4 inhibitors.

Researchers assessed the diagnostic accuracy of nanopore sequencing for the early identification of pulmonary tuberculosis.

A meta-analysis of children treated as outpatients for community-acquired pneumonia compared outcomes of short-course vs long-course antibiotic treatment.

New research re-examines the current concern that using moxifloxacin in the shorter regimen for drug-resistant TB might increase the risk for QT prolongation.

Researchers assessed whether antibiotic treatment differed on the basis of pneumococcal urinary antigen test results among patients hospitalized with community-acquired pneumonia.

Researchers assessed the protective effects of influenza vaccination among older adults with cardiovascular disease.

Does influenza vaccination protect patients hospitalized for diabetes against the risk for poor outcomes and complications?

A systemic review looked at the effect of diabetes on plasma concentrations and the bioavailability of rifampicin in patients with tuberculosis.

Researchers examined the relationship between multiple factors related to heart failure and worse outcomes in patients hospitalized for pneumonia.

In this meta-analysis, researchers assessed the relationship between cytomegalovirus and the risk for incident tuberculosis infection.

Researched compared the efficacy of erythromycin with clarithromycin for the treatment of community-acquired pneumonia.

What is the efficacy of ongoing treatment of Mycobacterium abscessus pulmonary disease with IV amikacin in patients with persistent culture positivity?

Researchers assessed outcomes and risk factors associated with thromboembolic events among patients with COVID-19 pneumonia.